DOCSLIB.ORG

Local Anesthetics

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series LUNCH AND LEARN Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 February 10, 2017 Featured Speaker: Julie A. Golembiewski, PharmD Clinical Associate Professor, Department of Pharmacy Practice Clinical Associate Professor of Anesthesiology University of Illinois at Chicago Colleges of Pharmacy and Medicine CE Activity Information & Accreditation ProCE, Inc. (Pharmacist and Tech CE) 1.0 contact hour Funding: This activity is self‐funded through PharMEDium. It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Dr. Golembiewski has no relevant commercial and/or financial relationships to disclose. 2 ProCE, Inc. www.ProCE.com 1 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series Online Evaluation, Self-Assessment and CE Credit . Submission of an online self‐assessment and evaluation is the only way to obtain CE credit for this webinar . Go to www.ProCE.com/PharMEDiumRx . Print your CE Statement online . Live CE Deadline: March 10, 2017 . CPE Monitor – CE information automatically uploaded to NABP/CPE Monitor upon completion of the self‐assessment and evaluation (user must complete the “claim credit” step) Attendance Code Code will be provided at the end of today’s activity Attendance Code not needed for On‐Demand 3 Ask a Question . Submit your questions to your site manager. Questions will be answered at the end of the presentation. Your question. ? 4 ProCE, Inc. www.ProCE.com 2 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series Resources . Visit www.ProCE.com/PharMEDiumRx to access: – Handouts – Activity information – Upcoming live webinar dates – Links to receive CE credit 5 Sterile Drug Products Used in the Anesthesia Setting – Part 2 Julie Golembiewski PharmD February 10, 2017 6 ProCE, Inc. www.ProCE.com 3 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series THE OPERATING ROOM Anesthesia Care Provider Surgeon 7 CARDIOVASCULAR DRUGS ADRENERGIC RECEPTORS Receptor Location Response (Agonist activity) Alpha 1 Vascular smooth muscle, Contraction heart Alpha 2 Vascular smooth muscle Contraction Beta 1 Heart Increased force and rate of contraction Beta 2 Smooth muscle (lungs, Relaxation vascular) 8 ProCE, Inc. www.ProCE.com 4 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series CLASSIFICATION OF BETA-BLOCKERS Classification Agent Non-selective Propranolol (blocks beta 1 and beta 2 decreases HR) Beta 1 selective Esmolol, metoprolol (decreases force and rate of contraction decreases HR) Alpha-blocking activity Labetolol >> beta-blocking activity (relaxes vascular smooth muscle decreases BP) 9 Beta Blockers Property Esmolol Metoprolol Pharma- Beta 1 antagonist Beta 1 antagonist cology Reduces HR and, Reduces HR and, to a much lesser to a much lesser extent, BP extent, BP Peak effect ̴ 5 minutes ̴ 10 minutes (IV) Duration (IV) 10 – 30 minutes ̴ 6 hours Usual dose 10 - 20 mg, 2 mg up to 0.5 mg/kg 10 ProCE, Inc. www.ProCE.com 5 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series Antihypertensives Property Hydralazine Labetolol Pharmacology Direct relaxation of Alpha 1 blocker, vascular smooth nonselective beta muscle antagonist Reduces BP Reduces BP, less effect on HR than propranolol Peak effect (IV) 5 – 20 minutes 5 – 15 minutes Duration (IV) 1 – 4 hours 2 – 18 hours Clinical Reflex tachycardia Less reflex Considerations tachycardia due to beta blocker effects Usual dose 5 mg 5 – 10 mg 11 VASOPRESSORS Property Phenylephrine Norepinephrine Pharmacology Alpha 1 agonist Alpha 1 agonist (vasoconstriction) (vasoconstriction) Beta 1 and some Beta 2 effects Relaxing effect on venous resistance enhanced venous return to heart increased CO with little effect on HR BP Increased Increased HR Decreased No change or increased Contractility No change or Increased decreased Venous return Increased Decreased Cardiac output Decreased Increased Typical IV bolus 40 – 100 mcg 2 – 8 mcg dose Norepinephrine increases BP by arterial vasoconstriction and an increase or maintenance of HR, stroke volume and cardiac output 12 ProCE, Inc. www.ProCE.com 6 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series EPHEDRINE VS. EPINEPHRINE Property Ephedrine Epinephrine Pharmacology Indirect stimulation Beta 1, beta 2 and of alpha 1 and in higher doses, beta 1 receptors alpha 1 Increases BP, HR, Increases HR, contractibility and cardiac output, BP cardiac output (less than others) bronchodilator 13 OPIOIDS 14 ProCE, Inc. www.ProCE.com 7 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series OPIOIDS Indications Agents • Blunt hemodynamic Fentanyl, sufentanil, response to: remifentanil, morphine, hydromorphone • Laryngoscopy • Surgical stimulation • Provide analgesia Considerations • Reduce anesthetic Onset requirement Duration Route of elimination Opioids alone do NOT provide anesthesia 15 Property Morphine Hydromorphone Fentanyl (Dilaudid) Onset 5 min ≤ 5 min ≤ 2 min Peak 15 - 20 min 10 – 20 min 5 – 7 min Duration ̴ 3 – 4 hours ̴ 2 – 3 hours 30 – 60 min Renal dysfunction Active metabolite OK OK can accumulate Equianalgesic 1 mg 0.2 mg 12.5 mcg dose (plasma) (brain) Anesthesiology. 2010;112:226. 16 ProCE, Inc. www.ProCE.com 8 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series Sufentanil – 5 – 10 times more potent than fentanyl • Usual dose: 5 – 20 mcg IV bolus – Similar onset and peak, but more rapidly eliminated than fentanyl when multiple doses (or infusion) administered Remifentanil – Slightly more potent than fentanyl • Usual dose: 12.5 – 25 mcg IV bolus – Rapidly eliminated by nonspecific plasma and tissue esterases – Shortest duration of action ( ̴ 10 minutes) • Infusion (usual range: 0.025 mcg/kg/min – 0.2 mcg/kg/min) 17 Context-Sensitive Halftime Anesthesiology. 1993;79:881–892 . 18 ProCE, Inc. www.ProCE.com 9 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series OPIOID ADVERSE EFFECTS • Nausea, vomiting, constipation • Sedation, dizziness • Itching • Bradycardia (intra-op boluses) • Apnea, respiratory depression 19 LOCAL ANESTHETICS 20 ProCE, Inc. www.ProCE.com 10 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series Local Anesthetics Agent Onset Duration Max Dose * Comments Chloroprocaine Fastest Short 800 (1,000) Epidural Lidocaine Rapid Intermediate 300 (500) Most frequently used Mepivacaine Moderate Intermediate 300 (500) Nerve block, epidural Bupivacaine Slow Long ** 175 (225) Local infiltration, (up to 12 nerve block, hrs) epidural, spinal Bupivacaine Slow Longest 266 Local infiltration liposome (up to 72 only hrs) Ropivacaine Slow Long ** 200 (200) Local infiltration, (up to 12 nerve block, hrs) epidural * In milligrams; epinephrine containing solution in parenthesis ** May be given as a continuous infusion for local infiltration, epidural, peripheral nerve block 21 SPINAL AND EPIDURAL ANESTHESIA Spinal needle 22 ProCE, Inc. www.ProCE.com 11 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series NERVE BLOCK ANESTHESIA Femoral nerve block Sciatic nerve block Source: http://www.privatehealth.co.uk/private-operations/Anaesthesia/femoral-nerve-block/ http://www.privatehealth.co.uk/private-operations/Anaesthesia/sciatic-nerve-block/ 23 LOCAL INFILTRATION (SURGEON) Source: 24 ProCE, Inc. www.ProCE.com 12 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series Local Anesthetic Infusions 25 PERIOPERATIVE ROUTES OF ADMINISTRATION OF LOCAL ANESTHETICS Surgeon Anesthesia Topical* Spinal Subcutaneous, deep tissue Epidural Transversus Intravenous abdominal plane* (lidocaine only) Tumescent Peripheral technique nerve block Intra- or periarticular * Surgeon or Anesthesia 26 ProCE, Inc. www.ProCE.com 13 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series PERIOPERATIVELidocaine ROUTES OF ADMINISTRATION FastOF LOCAL onset, ANESTHETICS Topical Short duration (1 - 3 hrs) Spinal Subcutaneous, deep tissue Epidural Transversus Intravenous abdominal plane Tumescent Peripheral technique nerve block Intra- or periarticular 27 BupivacainePERIOPERATIVE or Ropivacaine ROUTES OF ADMINISTRATION OF LOCAL ANESTHETICS Slow onset, long duration (4 – 18 hrs) Topical Spinal Subcutaneous, (bupivacaine only) deep tissue Epidural Transversus Intravenous abdominal plane Tumescent Peripheral technique nerve block Intra- or periarticular 28 ProCE, Inc. www.ProCE.com 14 Sterile Drug Products Used in the Anesthesia Practice Setting: Part 2 PharMEDium Lunch and Learn Series PERIOPERATIVE ROUTES OF ADMINISTRATIONLiposome Bupivacaine OF LOCAL ANESTHETICSFast onset, long duration (up to 72 hrs) Topical Spinal Subcutaneous, (bupivacaine only) deep tissue Epidural Transversus Intravenous abdominal plane Tumescent Peripheral technique
Recommended publications
  • Pain Management

    Pain Management

    BLBK137-Paul February 20, 2009 13:17 CHAPTER 8 8 Pain management Mark Nichols MD, Glenna Halvorson-Boyd PhD, RN, Robert Goldstein MD, Clifford Gevirtz MD, MPH and David Healow MD LEARNING POINTS r Proper selection of medications and nonpharmacological interventions reduces pain and anxiety and enhances patient satisfaction. r Several effective techniques exist for administration of local cervical anesthesia. Limited data support use of deep injections and adjunctive premedication with nonsteroidal antiinflammatory drugs. r The most common conscious sedation regimen used by North American abortion providers is a combination of fentanyl and midazolam. r Deep sedation and general anesthesia carry important benefits for certain patients, but they require specialized personnel and equipment. Introduction Pain associated with abortion Managing pain associated with abortion procedures is an es- Pain management remains an important challenge in abor- sential goal in the care of patients requesting pregnancy ter- tion practice, although studies suggest that progress in pain mination. Effective methods range from local cervical anes- control has been achieved over time in the USA. In a sur- thesia, with or without supplemental oral or intravenous vey in the late 1970s, 2,299 women having abortions with (IV) medications, to general anesthesia (GA). A number cervical anesthesia were asked to rate their pain as “mild, of factors influence the options available to patients, in- moderate, or severe.” Forty-six per cent called the pain mod- cluding local regulations, safety considerations, facility in- erate, and 32% called it severe. [2] A survey conducted two frastructure and resources, cost, and insurance coverage. decades later of more than 2,000 patients at 12 abortion fa- In the USA, where most abortions occur in freestanding cilities in the USA found that 30% of patients felt no pain, clinics, cervical anesthesia with or without IV conscious 25% mild pain, 29% moderate pain, and 14% severe pain.
  • Neuroanesthesia Checklists

    Neuroanesthesia Checklists

    Neuroanesthesia Checklists Contents: 1. Surgical resection of Arteriovenous Malformation (AVM) 2. Deep Brain Stimulation (DBS) 3. Flexible Endoscopic Intubation 4. Checklist: Prone Positioning Lumbar Spine Surgery 5. Moyamoya / Extra- Intracranial Bypass 6. Lidocaine Infusions for Trigeminal Nerve Neurolysis in Neuroradiology Suite 7. Checklist for Stroke – Endovascular Therapy 8. Craniotomy for Resection of Supratentorial Tumor 9. SNACC Neuroanesthetic Emergencies Critical Event Treatment Guides Surgical resection of Arteriovenous Malformation (AVM) Surgical characteristics Duration of surgery Variable. Between 6 to 12 hours. Expected blood loss Variable. Potential high blood loss during the procedure. Blood group confirmation is mandatory. Positioning Depending on the location of AVM Antibiotic therapy As per surgical protocol. Anesthesia Pre-Anesthesia Optimize pre-existing medical conditions. Review the size, location and characteristics of AVM. Was endovascular embolization performed prior to surgery? Mode of Anesthesia Usually general anesthesia. Consider TIVA (Propofol). Airway Standard management / avoid sympathetic response to laryngoscopy. Ventilation Normoventilation. Mild hyperventilation (paCO2 28-33 mmHg) may be indicated in selected cases. Target MAP Initially maintain normotension. Discuss BP management with surgeon, often deliberate hypotension needed. Blood Gases Perform frequently – and as needed to control pCO2. Temperature Maintain normothermia. Use Bear Hugger blankets. Avoid hyperthermia. Transfer Consider ICU for postoperative BP control Special Potential major blood loss during procedure. considerations Be prepared to provide deliberate hypotension. Consider e.g. Esmolol (1 mg/kg, 0.5 mg/kg/min infusion), Labetalol, Nitroglycerin infusion. Often intraoperative angiogram. Indocyanine green dye sometimes used. Patient monitoring and vascular access Patient monitoring Standard CAS monitoring. Peripheral IV access Minimal 2 peripheral IV lines, one suitable for rapid infusion.
  • Orientation for New Clinicians

    Orientation for New Clinicians

    PROFESSIONAL AFFAIRS ORIENTATION FOR NEW CLINICIANS TABLE OF CONTENTS SCORE: CLINICAL ORIENTATION ........................................................................................... 4 I. SCHEDULE ........................................................................................................................ 5 A. QGenda ......................................................................................................................... 5 B. Weekly Schedule .......................................................................................................... 5 C. OR Daily Schedule ....................................................................................................... 5 D. Anesthesia Daily Call Team ......................................................................................... 6 II. ELECTRONIC MEDICAL RECORD ............................................................................... 6 A. BIDMC Portal: ............................................................................................................. 6 B. Anesthesia Intranet ....................................................................................................... 6 C. Perioperative Information Management System (PIMS) ............................................. 7 D. Talis: ............................................................................................................................. 7 E. Online Medical Record (OMR): ..................................................................................
  • Standards for Office Based Anesthesia Practice

    Standards for Office Based Anesthesia Practice

    Standards for Office Based Anesthesia Practice Certified Registered Nurse Anesthetists (CRNAs) have long been the predominant anesthesia professional and leaders in providing anesthesia services in physicians’ offices. As the professional organization representing nurse anesthetists, the American Association of Nurse Anesthetists (AANA) advocates high quality, appropriate standards of care for all patients in all settings, including the office based practice setting. As in other settings, CRNAs provide anesthesia working with physicians such as surgeons, anesthesiologists and, where authorized, podiatrists, dentists and other healthcare professionals. The AANA has been at the forefront in establishing clinical practice standards, including patient monitoring standards. The standards for care in the office based setting are congruent with the AANA Scope and Standards for Nurse Anesthesia Practice and are intended to: 1. Provide assistance to CRNAs and other practitioners by promoting a common base for the delivery of quality patient care in the office based setting. 2. Assist the public in understanding what to expect from the practitioner. 3. Support the basic rights of patients. Although the standards are intended to promote high quality patient care, they cannot assure specific outcomes. There may be exceptional patient-specific circumstances that require deviation from a standard. The CRNA shall document any deviations from these standards (e.g., surgical interventions or procedures that invalidate application of a monitoring standard) and state the reason for the deviation on the patient’s anesthesia record. Anesthesia in the Office Setting There are some unique and specific responsibilities that should be considered prior to administration of anesthesia in the office setting. When considering an office based practice, anesthesia professionals should determine if there are appropriate resources to manage the various levels of anesthesia for the planned surgical procedures and the condition of the patient.
  • (12) United States Patent (10) Patent No.: US 8,092.426 B2 Molnar (45) Date of Patent: *Jan

    (12) United States Patent (10) Patent No.: US 8,092.426 B2 Molnar (45) Date of Patent: *Jan

    USOO8092426B2 (12) United States Patent (10) Patent No.: US 8,092.426 B2 Molnar (45) Date of Patent: *Jan. 10, 2012 (54) REGIONAL ANESTHESIA SYSTEMAND 5,647,373 A 7, 1997 Paltieli CART 5,700,147 A 12, 1997 Mills et al. 5,810,765 A 9, 1998 Oda 5,830,151 A 11/1998 HaZdic et al. (76) Inventor: James M. Molnar, Wyoming, OH (US) 6,022,337 A 2/2000 Herbst et al. - 6,055.458. A 4/2000 Cochran et al. (*) Notice: Subject to any disclaimer, the term of this 6,113,574 A 9/2000 Spinello patent is extended or adjusted under 35 6,179,829 B1 1/2001 Bisch et al. U.S.C. 154(b) by 0 days. 6,200,289 B1 3/2001 Hochman et al. This patent is Subject to a terminal dis- (Continued)Continued claimer. OTHER PUBLICATIONS (21) Appl. No.: 12/896,405 PCT International Search Report and Written Opinion for PCT/ US2009/042292 dated Dec. 16, 2009 (10 pages). (22) Filed: Oct. 1, 2010 (Continued) (65) Prior Publication Data Primary Examiner — Jackie Ho US 2011 FOO219 12 A1 Jan. 27, 2011 Assistant Examiner — Leah Stohr O O (74) Attorney, Agent, or Firm — Hasse & Nesbitt LLC; Related U.S. Application Data Ronald J. Richter; Donald E. Hasse (63) Continuation-in-part of application No. 12/114,634. filed on May 2, 2008, now Pat. No. 7,806,862. (57) ABSTRACT A regional anesthesia system and a cart for aiding in the (51) Int. Cl. placement of a regional anesthesia block without the need of A6M5/00 (2006.01) ancillary assistance.
  • The Medical Student's Anesthesia Pocketbook

    The Medical Student's Anesthesia Pocketbook

    The Medical Student’s Anesthesia Pocketbook University of Texas Health Science Center Houston Table of Contents ACKNOWLEDGEMENTS ......................................................................................................................... 2 ANESTHESIA OVERVIEW....................................................................................................................... 3 INTRODUCTION ......................................................................................................................................... 3 PREOPERATIVE HISTORY AND PHYSICAL ................................................................................................ 3 IV’S AND PREMEDICATION ....................................................................................................................... 5 ROOM SETUP AND MONITORS .................................................................................................................. 5 INDUCTION AND INTUBATION ................................................................................................................... 6 MAINTENANCE .......................................................................................................................................... 7 EMERGENCE.............................................................................................................................................. 8 PACU CONCERNS ....................................................................................................................................
  • Use of Human Patient Simulation to Teach Difficult Airway Management and Improve Patient Safety in the Nurse Anesthesia Student

    Use of Human Patient Simulation to Teach Difficult Airway Management and Improve Patient Safety in the Nurse Anesthesia Student

    USE OF HUMAN PATIENT SIMULATION TO TEACH DIFFICULT AIRWAY MANAGEMENT AND IMPROVE PATIENT SAFETY IN THE NURSE ANESTHESIA STUDENT by Karen Ellis Lucisano A dissertation submitted to the faculty of The University of North Carolina at Charlotte in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Health Services Research Charlotte 2012 Approved by: ______________________________ Dr. Laura Talbot _____________________________ Dr. Lucille Travis _____________________________ Dr. Claudia Flowers ______________________________ Dr. Joseph Coyle ____________________________ Dr. Adam Harbaugh ii ©2012 Karen Ellis Lucisano ALL RIGHTS RESERVED iii ABSTRACT KAREN ELLIS LUCISANO. Use of human patient simulation to teach difficult airway management and improve patient safety in the nurse anesthesia student. (Under the direction of DR. LAURA A. TALBOT) Introduction: The objective of this study was to determine if scenario-based training (SB) was more effective than task-based (TB) training in teaching a difficult airway algorithm to nurse anesthesia student. Methods: Participants were second year nurse anesthesia students. Simulation was used as both a training and testing modality. Subjects were given a 2 scenario simulation based pre-test and a written test, randomized to receive either 1) lecture and task-based training or 2) lecture and scenario-based training. They were then post-tested with the same 2 simulation scenarios and an objective matched written posttest. Performance was videotaped and evaluated by 2 expert observers based on performance against an idealized algorithm, amount and time of desaturation, and time to secure the airway. Data were analyzed using repeated measures ANOVA and students-t test. Levels of statistical significance were set at α of .05 (one-tail).
  • The General Questions of Anaesthesiology

    The General Questions of Anaesthesiology

    Ministry of Education and Science of Ukraine Ministry of Health of Ukraine Sumy State University V.D.Shyschuk, S.I.Redko, M.M.Ogienko GENERAL QUESTIONS OF ANAESTHESIOLOGY Study Guide Recommended by the Medical Institute Academic Council of Sumy State University Sumy – 2015 УДК 616-089.5 ББК 54.5 Ш 65 Recommended for publication by the Medicine Faculty Academic Council of Sumy State University (the Minutes N 3 of 23.11.2015 ) Authors: V.D.Shyschuk, Doctor of Medicine, Professor S.I.Redko, Assistant M.M.Ogienko, PhD, Assistant Reviewers: V.O. Litovchenko – Doctor of Medicine, Professor of Department Emergency Medicine, Ortopedics and Traumatology. Kharkiv Nacional Medical University. O. I. Smiyan – Doctor of Medicine, Professor. Head of the Department of Pediatrics postgraduate education of Sumy State University. O.L.Sytnik – PhD, Associate Professor of Surgery Department of Sumy State University. Shyschuk V.D. Ш 65 General questions of anaesthesiology: study guide / V.D.Shyschuk, S.I.Redko, M.M.Ogienko. – Суми: ТОВ «ВПП «Фабрика друку», 2015. – 168 с. ISBN 978-966-97423-4-6 This book covers information about basic principles and methods of the modern anesthesiology. For English-speaking students of higher educational institutions III-IV levels of accreditation, postgraduates. ISBN 978-966-97423-4-6 УДК 616-089.5 ББК 54.5 © V.D.Shyschuk, S.I.Redko, M.M.Ogienko, 2015 © ТОВ «Видавничо-поліграфічне підприємство «Фабрика друку», 2015 CONTENTS Topic 1. PREOPERATIV PREPARATION …………... 4 Topic 2. ANESTESIA……………………...…………… 39 Topic 3. POSTANESTESIA CARE………………….... 137 Referenses ……………………………………………… 167 3 Topic 1. PREOPERATIV PREPARATION The main aim: to be able to prepare the patient for surgery, to assess the risk of anesthesia, choose the appropriate type of anesthesia, premedication appoint, prepare equipment and instruments for anesthesia.
  • Guidelines on Surgery and Anesthesiology Pharmaceutical Services

    Guidelines on Surgery and Anesthesiology Pharmaceutical Services

    482 Medication Therapy and Patient Care: Specific Practice Areas–Guidelines ASHP Guidelines on Surgery and Anesthesiology Pharmaceutical Services Purpose 5. Improved revenue generation through accurate patient billing; In hospitals, surgery and anesthesiology generally have been 6. Improved documentation of drugs administered to pa- 6 without direct pharmacist involvement. Drugs have been tients; available through a stock-distribution system maintained 7. Clinical activities; by operating-room (OR) personnel, and documentation of 8. Formulary management; controlled-substance use has often been handled by person- 9. Drug accountability and control, including adherence nel other than those administering the drugs. More impor- to organizational drug-use guidelines; tant, without direct pharmacist involvement, patient-related 10. Quality assurance and continuous quality improve- issues that are best addressed by a pharmacist usually have ment; been handled by other health care personnel out of neces- 11. Compliance with standards of the Joint Commission on sity. ASHP believes that pharmaceutical services (including Accreditation of Healthcare Organizations (JCAHO); drug-use control) to these areas should be provided by phar- 12. Informational, educational, and research activities; macists, ideally with their direct presence. In many hospitals 13. Involvement with the use of drug administration this is accomplished through an onsite satellite pharmacy.1–5 devices; and The purpose of these guidelines is to help pharmacists 14. Enhanced interdisciplinary decision-making. identify services they could provide in the areas of surgery and anesthesiology, decide on the scope of these services, Drug Preparation and Distribution and develop performance improvement plans. In addition, the appendix provides guidance for justifying and implement- In most ORs, the drug preparation and distribution functions ing a satellite pharmacy.
  • A System for Anesthesia Drug Administration Using Barcode Technology: the Codonics Safe Label System and Smart Anesthesia Manager™

    A System for Anesthesia Drug Administration Using Barcode Technology: the Codonics Safe Label System and Smart Anesthesia Manager™

    RESEARCH REPORT A System for Anesthesia Drug Administration Using Barcode Technology: The Codonics Safe Label System and Smart Anesthesia Manager™ Srdjan Jelacic, MD,* Andrew Bowdle, MD, PhD,* Bala G. Nair, PhD,† Dolly Kusulos, RPh,† Lynnette Bower, PharmD,† and Kei Togashi, MD* BACKGROUND: Many anesthetic drug errors result from vial or syringe swaps. Scanning the barcodes on vials before drug preparation, creating syringe labels that include barcodes, and scanning the syringe label barcodes before drug administration may help to prevent errors. In contrast, making syringe labels by hand that comply with the recommendations of regulatory agencies and standards-setting bodies is tedious and time consuming. A computerized sys- tem that uses vial barcodes and generates barcoded syringe labels could address both safety issues and labeling recommendations. METHODS: We measured compliance of syringe labels in multiple operating rooms (ORs) with the recommendations of regulatory agencies and standards-setting bodies before and after the introduction of the Codonics Safe Label System (SLS). The Codonics SLS was then combined with Smart Anesthesia Manager software to create an anesthesia barcode drug administration system, which allowed us to measure the rate of scanning syringe label barcodes at the time of drug administration in 2 cardiothoracic ORs before and after introducing a coffee card incentive. Twelve attending cardiothoracic anesthesiologists and the OR satellite pharmacy participated. RESULTS: The use of the Codonics SLS drug labeling system resulted in >75% compliant syringe labels (95% confidence interval, 75%–98%). All syringe labels made using the Codonics SLS system were compliant. The average rate of scanning barcodes on syringe labels using Smart Anesthesia Manager was 25% (730 of 2976) over 13 weeks but increased to 58% (956 of 1645) over 8 weeks after introduction of a simple (coffee card) incentive (P < 0.001).
  • Anesthesia Emergencies This Material Is Not Intended to Be, and Should Not Be Considered, a Substitute for Medical Or Other Professional Advice

    Anesthesia Emergencies This Material Is Not Intended to Be, and Should Not Be Considered, a Substitute for Medical Or Other Professional Advice

    Anesthesia Emergencies This material is not intended to be, and should not be considered, a substitute for medical or other professional advice. Treatment for the conditions described in this material is highly dependent on the individual circumstances. And, while this material is designed to offer accurate information with respect to the subject matter cov- ered and to be current as of the time it was written, research and knowledge about medical and health issues is constantly evolving and dose schedules for medications are being revised continually, with new side effects recognized and accounted for regularly. Readers must therefore always check the product information and clinical procedures with the most up-to-date published product informa- tion and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulation. The publisher and the authors make no representations or warranties to readers, express or implied, as to the accuracy or completeness of this material. Without limiting the foregoing, the publisher and the authors make no representations or warranties as to the accuracy or effi cacy of the drug dosages mentioned in the material. The authors and the publisher do not accept, and expressly disclaim, any responsibility for any liability, loss or risk that may be claimed or incurred as a consequence of the use and/or application of any of the contents of this material. Anesthesia Emergencies K eith J . R uskin, MD Professor of Anesthesiology and Neurosurgery Yale University School of Medicine New Haven, Connecticut S tanley H . R osenbaum, MD Professor of Anesthesiology, Medicine, and Surgery Yale University School of Medicine New Haven, Connecticut 1 3 Oxford University Press, Inc., publishes works that further Oxford University’s objective of excellence in research, scholarship, and education.
  • RULES and REGULATIONS DEPARTMENT of ANESTHESIOLOGY Revised March 2012

    RULES and REGULATIONS DEPARTMENT of ANESTHESIOLOGY Revised March 2012

    RULES AND REGULATIONS DEPARTMENT OF ANESTHESIOLOGY Revised March 2012 Section I-Administration Scope of service . 3 Major Diseases/conditions managed 3 Department philosophy and objectives………………………………………………………………… 3 Guidelines for the Ethical Practice of Anesthesiology…..………………………………………...……4 Organization of the Anesthesia Department 4 i. Physician responsibilities . 4 ii. Medico-Administrative organization and responsibilities 4 iii. Responsibilities of Department Chair, Anesthesiologists, and Certified Registered Nurse Anesthetists 5 iv. Delineation of clinical privileges 7 Section II-Performance Improvement Purpose ..9 Scope and Responsibility……………………………………………………………………....9 Review Methodology ………………………………………………………………………….10 Reporting and Reappraisal …………………………………………………………………….11 Relationships with Hospital-wide Programs 11 Corrective Action 11 Authority . 11 Section III -Department Responsibilities Anesthesia Coverage and Availability 11 ASA Physical Status Definition 11 Emergency Service Coverage . 12 Section IV -Infection Control Guidelines Personnel 12 Equipment 12 Resources and References . 12 Section V-Safety Guidelines 13 Section VI-Education 13 Section VII- Care of Patients Informed Consent . 14 Do Not Resuscitate orders . 14 Standards for Patient Care 14 Pre-operative tests 14 Basic Standards for preanesthesia care 15 Standards for basic anesthetic monitoring 15 Standards for post anesthesia care . 17 Documentation of anesthesia care 18 Section VIII-Post Anesthesia Care Unit Purpose 19 Organization . 19 Admission Criteria 19